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objectives: The efficacy of drug-based treatments and psychological interventions on 
the primary negative symptoms of schizophrenia remains limited. Recent literature has 
distinguished negative symptoms associated with a diminished capacity to experience, 
from those associated with a limited capacity for expression. The positive emotions 
program for schizophrenia (PEPS) is a new method that specifically aims to reduce the 
syndrome of a diminished capacity to experience.
Methods: The intervention’s vital ingredients were identified through a literature review 
of emotion in schizophrenia and positive psychology. The program has been beta-tested 
on various groups of health-care professionals.
Results: A detailed description of the final version of PEPS is presented here. The 
French version of the program is freely downloadable.
Conclusion: PEPS is a specific, short, easy to use, group-based intervention to improve 
pleasure, and motivation in schizophrenia. It was built considering a recovery-oriented 
approach to schizophrenia.
Keywords: schizophrenia, anhedonia, apathy, pleasure, motivation, psychosocial interventions
INtRodUCtIoN
Negative symptoms have long been recognized as a central feature of the phenomenology of 
schizophrenia, dating back to early descriptions by Kraepelin and Bleuler (1). They negatively 
affect patients’ longitudinal social, occupational, and functional outcomes, as well their long-
term recovery (2–5). Whereas positive symptoms (hallucinations, delusions) reflect an excess or 
distortion of normal functions, and negative symptoms (blunted affect, alogia, apathy–avolition, 
anhedonia, inattentiveness) represent the absence or reduction of normal emotions and behaviors. 
Negative symptoms are classified as primary or secondary. Primary negative symptoms comprise 
the core features intrinsic to schizophrenia itself. Secondary negative symptoms are transient; 
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they are attributable and temporally related to the effects of 
such factors as unrelieved positive symptoms, depression, the 
adverse effects of antipsychotic drugs (akinesia), or the social 
isolation imposed by the stigma of schizophrenia. Primary and 
secondary negative symptoms may be similar in clinical expres-
sion, despite their contrasting etiologies (6). Often, secondary 
negative symptoms diminish with the resolution of their causa-
tive factors.
Limitations of Current techniques
The efficacy of drug-based treatments and psychological inter-
ventions on primary negative symptoms remains limited, how-
ever (7–9). Fusar-Poli et al. (9), in their meta-analysis of 6,503 
patients in the treatment arm and 5,815 patients in the placebo 
arm, showed that most treatments reduced negative symptoms at 
follow-up relative to placebo: second-generation antipsychotics, 
antidepressants, combinations of pharmacological agents, gluta-
matergic medications, and psychological interventions. However, 
none of the treatments used reached the threshold for clinically 
significant improvement as measured by clinicians using the 
Clinical Global Impression Severity Scale. The mean percent-
age change in treatment groups was 16.1%, whereas the control 
group changed by an average 7.9%. Improvements by treatment 
group, compared with the control group, varied between 4.8% for 
first-generation antipsychotics and 12.7% for psychological treat-
ments. There is a clear clinical need for developing treatments 
for negative symptoms. The lack of clinically meaningful efficacy 
of drug or psychological treatments is in line with clinicians’ 
practical experiences (7, 9). The existing psychological treatments 
have limitations (10). Family interventions to reduce negative 
symptoms appear promising when combined with other inter-
ventions. However, patients who have family members willing 
to be involved in treatment may merely represent a subgroup of 
people with schizophrenia. Furthermore, families who are more 
willing to participate in psychosocial interventions may provide 
patient’s with greater support anyway and thus may not represent 
the broader population. Psychosocial interventions, such as 
cognitive behavior therapy (CBT), social skills training (SST), 
mindfulness-based intervention (MBI), family therapy (FT), or 
cognitive remediation (CR), combined with SST require highly 
trained therapists. The vast majority of studies were not spe-
cifically designed to target negative symptoms, and most assessed 
negative symptoms overall, without looking for the specific effects 
of the intervention. Several interventions were provided over long 
durations, requiring a great investment in time by the patients. 
For example, combining CR with SST may be useful for reduc-
ing negative symptoms, particularly social withdrawal, affective 
flattening, and motor retardation (11, 12), or a global score of 
negative symptoms (13). These interventions required 32–100 h 
of training. One 3-year study (14) indicated that improvements 
in negative symptoms did not occur until the second and third 
years of therapy. However, a second study (15, 16) indicated 
improvements in negative symptoms at 12 and 24 months. These 
comprehensive packages are promising but involve relatively long 
interventions and call for a broad range of therapeutic techniques. 
Except SST, very few interventions are provided as group therapy. 
Group interventions are particularly important since they are 
more commonly used in community psychiatry settings, where 
most patients receive treatment services.
experimental objectives
Recent literature has distinguished the negative symptoms associ-
ated with a diminished capacity to experience (apathy, anhedonia) 
from those who were associated with a limited capacity for expres-
sion (emotional blunting, alogia) (17–20). The apathy–anhedonia 
syndrome tends to be associated with a poorer prognosis than the 
symptoms related to diminished expression, suggesting that it is 
the more severe facet of the psychopathology (19). This syndrome 
is also related to the duration of the untreated psychosis, family 
history of schizophrenia, and the patient’s employment status 
during first-episode schizophrenia (21). The distinction between 
diminished experience and limited expression syndromes allows 
more specific approaches to these problems.
A symptom-specific strategy has been used in the develop-
ment of specific therapeutic techniques for positive symptoms 
(22, 23) and led to the development of more effective interven-
tions, such as CBT for delusions or hallucinations (24). More 
recently, metacognitive training (MCT), which targets associated 
specific cognitive biases with psychosis, has appeared effective in 
reducing positive symptoms (25–27). A similar strategy appears 
to be a good way to develop psychological interventions for 
negative symptoms. Recent research has also shown that more 
specific symptom or syndrome approaches enabled a better 
identification of specific psychological mechanisms. For example, 
the endorsement of beliefs regarding low expectations of suc-
cess, and perceptions of limited personal resources, are robustly 
associated with negative symptoms of diminished experience 
(anhedonia, avolition, asociality), but are not associated with 
negative symptoms of diminished expressivity (flattened affect, 
alogia). Similarly, defeatist performance beliefs are slightly related 
to diminished experience, but not at all related to diminished 
expression (28). An impaired ability to envision the future is 
associated with apathy (29). These results suggest that within 
the syndrome of diminished capacity to experience, apathy and 
anhedonia may be the results of the same underlying process: 
that is, a diminished capacity to anticipate a particular experience 
or the achievement of a pleasurable goal (18), or a motivational 
impairment (30). This article presents a new method. It is hoped 
that it will open new avenues of experimental investigation for 
interventions to improve the diminished expression syndrome in 
schizophrenia. The intervention is called the positive emotions 
program for schizophrenia (PEPS). It comprises a program of 8 
1-h sessions applied to groups of 5–10 participants. The results 
concerning the participants have been published elsewhere (31). 
This paper presents the development of the program before the 
pilot study with participants.
Methods VALIdAtIoN
Identification of the Component of PePs
Anhedonia has been defined as a reduction in the ability to 
experience pleasure. Despite its clinical significance, research 
into anhedonia has produced a paradoxical set of findings, raising 
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questions about its nature. On the one hand, using self-reported 
measures of trait social and physical anhedonia, individuals with 
schizophrenia typically report experiencing lower levels of pleas-
ure in their daily lives than non-patients (32–35). On the other 
hand, in laboratory studies using emotionally evocative stimuli, 
individuals with schizophrenia have repeatedly reported experi-
encing levels of pleasant emotions similar to, or even stronger than 
control subjects (36–38). Germans and Kring (39) resolved this 
inconsistency by suggesting that patients do not anticipate that 
pleasurable activities will indeed be pleasurable, even though they 
experience pleasant emotions when presented with pleasurable 
stimuli. This explanation is founded on the distinction between 
appetitive/anticipatory pleasure (i.e., anticipating the potential 
pleasure of taking part in a future activity) and consummatory 
pleasure (i.e., the actual level of pleasure experienced directly 
from participating in an activity). Anticipatory pleasure is linked 
to motivational processes that stimulate goal-directed behaviors, 
whereas consummatory pleasure is associated with satiety. The 
Temporal Experience of Pleasure Scale (TEPS) is a trait measure 
of pleasure (40) that distinguishes between “momentary pleasure” 
and “anticipation of future pleasant activities.” A TEPS score study, 
comparing subjects with schizophrenia to controls, indicated that 
patients did not differ from controls on the consummatory scale; 
however, they reported significantly less anticipatory pleasure 
than controls (41). These results were replicated by the French ver-
sion of TEPS (42). Bringing out this new way of conceptualizing 
anhedonia in schizophrenia permits a redefinition and calibration 
of the symptom complex as a target for treatment. If patients with 
schizophrenia show a deficit in their ability to anticipate pleasure, 
rather than experience pleasure, then cognitive training might 
well help these individuals anticipate pleasure from foreseeable, 
future activities. Ideally, treatment would lead to a greater ability 
to anticipate pleasure, and this, in turn, would lead to a meaning-
ful increase in spontaneous daily activities. These considerations 
led us to explore the potential for an intervention that would 
train patients who complained of anhedonia, or a lack of desire 
to engage in activities, in the cognitive skills needed to increase 
their anticipatory pleasure (43). This first, exploratory pilot study 
included five participants with schizophrenia, presenting severe 
anhedonia, and stabilized on atypical antipsychotic medication. 
They received 10–25 h of training in anticipatory pleasure. Results 
showed that the patients improved on the anticipatory scale of 
TEPS. The patients’ daily activities were also increased accord-
ing to a time budget. These preliminary data were, of course, 
interpreted with caution, given the small study sample, but they 
seemed to show a promising path toward the development of new 
interventions to alleviate anhedonia in schizophrenia.
Further emotional deficits may be present in schizophrenia 
(44) and should be taken into account in the development of 
new interventions (45, 46). Strauss (46) suggested maximizing 
positive emotional experiences by using techniques developed in 
the field of affective science (47, 48) to increase the frequency and 
duration of positive emotional experiences. Five techniques have 
been found to specifically and reliably increase the frequency, 
intensity, and duration of positive emotions, including anticipat-
ing the enjoyment. The others were behavioral display (express-
ing emotions via non-verbal behaviors), being “in the moment” 
(directing controlled attention toward positive experiences when 
they occur-savoring), communicating and celebrating positive 
experiences with others, and recalling previously pleasurable 
events. Patients reported lower levels of pleasure in savoring 
past, present, and future events than did normal controls, and 
stated that they had low expectations of their self-efficacy (49). 
Individuals with schizophrenia also manifested a lesser ability 
to maintain positive emotions (50–52). Even though observable, 
outward signs of emotional expression were lessened in schizo-
phrenia, studies indicated that sufferers continued to display very 
subtle facial muscle movements (as measured by electromyogram) 
similar to, and in accordance with, their responses (53). Finally, 
to the best of our knowledge, it appears that communicating and 
celebrating positive events with others has not been studied in 
schizophrenia patients. However, one study showed that impaired 
perspective-taking  –  a component of cognitive empathy  –  was 
associated with functional capacity and community functioning, 
even after taking into account the influences of neurocognitive 
deficits and psychopathology (54).
With this as a background, Jérôme Favrod and Alexandra 
Nguyen conceived an intervention, which they named the “posi-
tive emotions program for schizophrenia,” to reduce anhedonia 
and apathy. The program teaches skills to help overcome defeatist 
thinking (55, 56) and to increase the anticipation and maintenance 
of positive emotions (44, 45). PEPS involves eight 1-h group ses-
sions, administered using visual and audio materials as part of a 
PowerPoint presentation of slides projected onto a screen.
Beta-testing Procedure
During its development, PEPS, as well as the sensitivity of self-
reporting instruments, was beta-tested on volunteer health-care 
professionals in order to improve its efficacy on anticipatory and 
consummatory pleasure, as well as savoring. Four 1-day training 
sessions of 7 h of PEPS were beta-tested on four different mixed 
groups of health-care professionals. At the end of each session, 
oral feedback and advice were collected, as were pre- and posttest 
assessments. Sessions 1–3 were conducted between February and 
March 2014 using version 1.0 of PEPS. Session 4 was conducted 
in March 2015 using the improved version 1.1 of PEPS, developed 
on the basis of the results of the previous sessions.
Participants
Participants were health-care professionals, including psychia-
trists, psychologists, nurses, occupational therapists, and social 
workers, interested in participating in the program’s development. 
No participant followed more than one session. Participation 
was anonymous, and the subjects gave only their sex and age. 
The clinical studies with PEPS have the agreement of the Vaud 
Cantonal Ethics Commission on Human Research (127/14 and 
446/15).
Instruments
The following measurement instruments were used:
• The Savoring Belief Inventory (SBI) is a self-reported scale for 
measuring beliefs about one’s capacity for savoring things. The 
scale has 24 items, including a positive scale (12 items) and 
tABLe 1 | Results of the field tests with health-care professionals.
session N Age (sd) sex F/M scales Pretest (sd) Posttest (sd) r t df two-tailed p Cohen’s d
1 21 32.4 (8.3) 17/4 TEPS anticipatory 45.8 (7.1) 48.3 (6.8) 0.86 −3.2 20 0.005 −0.68
TEPS consummatory 38.4 (4.8) 40.4 (4.8) 0.82 −3.1 20 0.006 −0.69
ACIPS anticipatory 31.4 (3.6) 31.8 (4.3) 0.86 −0.9 20 0.37 −0.19
ACIPS consummatory 51.9 (5.7) 51.7 (5.8) 0.87 0.3 20 0.71 −0.07
2 16 36.3 (8.6) 9/7 SBI total 41.4 (15.5) 47.3 (13.0) 0.93 −4.0 15 0.001 −1.12
3 27 38.0 (11.2) 21/6 ACIPS anticipatory 32.4 (3.5) 32.0 (6.8) 0.28 0.3 26 0.73 0.07
ACIPS consummatory 52.7 (5.3) 51.9 (11.5) 0.48 0.4 26 0.69 0.09
SBI total 36.0 (18.1) 46.0 (17.7) 0.82 −4.1 26 <0.001 −0.93
4 28 36.5 (10.9) 23/5 TEPS anticipatory 42.8 (8.1) 46.8 (5.5) 0.77 −4.2 27 <0.001 −0.90
TEPS consummatory 38.8 (6.6) 40.9 (6.4) 0.78 −4.0 27 <0.001 −0.49
ACIPS anticipatory 31.6 (4.9) 33.0 (5.2) 0.78 −2.3 27 0.03 −0.42
ACIPS consummatory 49.4 (8.0) 52.8 (5.2) 0.91 −3.5 27 0.002 −0.30
TEPS, Temporal Experience of Pleasure Scale; SBI, Savoring Belief Inventory; ACIPS, Anticipatory and Consummatory Interpersonal Pleasure Scale.
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a negative scale (12 items). The inventory has good validity 
and a high test–re-test reliability (57). It measures a person’s 
thinking regarding their capacity to savor positive experiences 
in terms of past experiences, current experiences, and future 
anticipation. The total SBI score is used.
• The TEPS contains 18 items included in two subscales: antic-
ipatory pleasure (10 items) and consummatory pleasure (8 
items) (58). Items targeting anticipatory pleasure reflect the 
pleasure felt when anticipating a positive or pleasant stimulus. 
Items measuring consummatory pleasure refer to the direct 
and immediate pleasure experienced upon exposure to a stim-
ulus. Items can be general or specific. Responses to items fall 
on a six-point Likert scale from 1 (very false for me) to 6 (very 
true for me). This scale has been validated in French (42). The 
total anticipatory and consummatory scores of TEPS are used.
• The Anticipatory and Consummatory Interpersonal Pleasure 
Scale (ACIPS) (59, 60) is designed to assess one’s ability to 
experience pleasure in the interpersonal domain. It is a 17-item 
self-reported questionnaire consisting of 7 anticipatory and 10 
consummatory items. ACIPS is scored on a six-point Likert 
scale, ranging from 1 (very false for me) to 6 (very true for 
me). The format is therefore quite similar to that of TEPS. The 
difference between the two scales lies mainly in terms of the 
items’ content. TEPS focuses on personal pleasure and ACIPS 
on interpersonal pleasure. The total anticipatory and consum-
matory scores of ACIPS are used.
data Analysis
Two-tailed paired sample t-tests of pre- and posttest results 
were calculated using IBM SPSS Statistics Version 22. Cohen’s d 
effect sizes were calculated for within-subjects in correcting for 
dependence among means. Formula 8 from Morris and DeShon 
(61) was also used.
ResULts
Results of the Beta tests
Table 1 shows that, in session 1, the 21 participants improved on 
their scores significantly and clinically on the anticipatory and 
consummatory scales of TEPS, but not on ACIPS. Session 2 tested 
PEPS using the SBI scale, and scores improved clinically and sig-
nificantly for the 16 participants. Session 3 replicated the previous 
results of ACIPS and the SBI with 27 participants. Since version 
1.0 did not improve interpersonal pleasure scores as measured 
by ACIPS, version 1.1 was upgraded to put more emphasis on 
this factor. Version 1.1 includes meditations focusing on caring 
for others and exercises involving interpersonal pleasure. Version 
1.1 was beta-tested in session 4. The 28 participants in session 
4 improved their scores for both TEPS and ACIPS. No adverse 
effects were observed or reported during the four sessions with a 
total 92 different participants.
detailed description of the Final Version 
of PePs
The pedagogical concept underpinning PEPS was designed 
according to Kolb and Kolb’s model (62) of experiential learning. 
This model sees the learning process as the transformation of an 
experience into personal knowledge. The sequential organiza-
tion of the learning activity starts with the learner experiencing 
something (the concrete experience phase). This is followed by a 
stage of distancing oneself from the experience through a period 
of observation and reflection that seeks to give the experience 
meaning (the reflective observation phase). Distancing oneself 
from the experience broadens the learner’s understanding, gener-
alizing, and developing concepts through more abstract thought 
(the abstract conceptualization phase). The learner then initiates 
an experimental approach to validate the newly acquired knowl-
edge through reality tests (the active experimentation phase). 
This model’s major contribution is its dynamic conception of 
learning, seen as “a process, not in terms of results” (63). The 
model claims to provide a supportive environment for all learners 
since it is based on adults’ different learning strategies and styles, 
all of which can be activated through the four phases. Therefore, 
Kolb’s model is relevant to a therapeutic program insofar as its 
design corresponds to a sequential logic – alternating phases of 
experience and reflection. The logo at the top-left of the each slide 
is a reminder to group leaders as to which phase the session is in.
The program uses a collaborative, egalitarian approach. Group 
facilitators participate in sessions just as the participants do, by 
doing the exercises, sharing their experiences, and carrying out 
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the given tasks. Group facilitators receive a day’s training before 
leading a group themselves and are supervised during two 1-h 
periods during the program.
Each session includes a number of the following steps. Part 1 
begins with a welcome, followed by a 5-min relaxation–medita-
tion exercise. In part 2, group leaders go over the homework task 
given during the previous session. Part 3 involves an exercise in 
challenging specific defeatist thoughts, which are presented using 
the program’s two fictitious heroes – Jill and Jack. Jill, for example, 
expresses such defeatist thinking as “I can’t relax; I’m useless.” The 
participant’s role is to challenge her belief, initially by assigning 
different reasons to why Jill has difficulty relaxing. They learn to 
find reasons that might be linked not only to the program’s heroine 
but also to other people or her environment. They subsequently 
try to develop an alternative, more positive way of thinking.
The following slides show how the exercise appears to the 
participants. This first slide presents a defeatist belief.
The next slide presents questions to find a more balanced set 
of reasons to explain Jill’s belief that she is unable to relax. Since 
defeatist beliefs are often linked to the internal attribution of 
failures, participants are asked to find a set of different reasons to 
explain why Jill was not able to relax. These questions are asked by 
the group leaders to the participants. Each of the eight sessions of 
PEPS will address a defeatist belief using the same methods in order 
to facilitate patients’ understanding of how the method works.
The third slide only appears after the participants have given 
answers to slide 2. Other suggestions are also given to comple-
ment or confirm the work they did for the previous slide.
The fourth slide asks the participants to give an alternative to 
Jill’s conclusion and defeatist belief that she is useless.
The final slide in this sequence about changing defeatist beliefs 
gives suggestions to complement or confirm the work the partici-
pants did for the previous slide.
Subsequently, and according to the session’s theme, partici-
pants learn and practice a new skill to improve their anticipation 
or maintenance of pleasure. The session ends with group leaders 
setting the homework task that the participants must accomplish 
for the next session.
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The skills taught include savoring a pleasant experience, 
expressing emotions by increasing behavioral expression, 
making the most of or capitalizing on positive moments, 
and anticipating pleasant moments in the future. Savoring a 
pleasant experience involves becoming aware of that pleasure 
or of the positive emotions the participant feels at a given 
moment (47). For example, participants are asked to look at a 
picture of pleasant countryside or listen to soothing music, and 
hence become aware of the pleasurable experience of doing 
this and thus appreciate it. Increasing behavioral expression 
of emotions involves using facial expressions or gestures to 
accompany that positive emotion. The participants are asked 
to imitate pictures of actors expressing a positive emotion and 
to become aware of the sensations this produces. The next slide 
introduces the exercise.
The next slide is an example of a picture to imitate.
The following slide allows participants to think about the 
exercise. Group leaders will help each participant to share 
their feelings during the exercise. The group leaders will 
also describe what they have felt, in order to help demon-
strate ways of sharing experiences and guide participants in 
self-observation.
Making the most of positive moments entails communicat-
ing and celebrating positive events with others. For example, 
participants are asked to describe positive events to one another 
through role playing. The next slides show a complete sequence of 
training with its experiential learning steps: concrete experience, 
reflective observation, abstract conceptualization, and active 
experimentation. During the concrete experience phase, partici-
pants experience the skill they are to be taught. During reflective 
observation phase, they consciously express and formulate the 
ingredients of that experience. During abstract conceptualization 
phase, the participants receive theoretical information about the 
skill they are being taught. Finally, during active experimenta-
tion phase, they practice the skill in their natural environment 
as homework. The homework is reviewed at the beginning of the 
next session.
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Anticipating pleasant moments involves imagining the sensa-
tions produced by positive future events. This strategy is meant to 
guide the participants through different positive feelings and emo-
tions. It can engage their senses, for example, by imagining they 
are eating a smooth, shiny, crunchy, tasty, sweet-smelling fruit, 
or by anticipating the emotion produced and the physical sensa-
tions experienced upon the completion of a pleasurable physical 
or social activity. A simple homework task is assigned to be done 
between each session. For example, this could be choosing an 
image or an object that provokes a positive emotion or feeling in 
the participant, who must then bring it back and describe it to the 
group. The original French version of PEPS can be downloaded 
for free at http://www.seretablir.net/outils-interventions/peps/.
dIsCUssIoN
Key Findings
Drug and psychological treatments for the negative symptoms 
of schizophrenia have shown poor clinical efficacy. Furthermore, 
they require lengthy therapeutic interventions involving highly 
skilled professionals. This paper presents a specific, short, easy to 
use, group-based intervention to improve pleasure, and motiva-
tion in schizophrenia. A more targeted syndrome approach was 
grafted to a model of the advancement of psychological therapies 
for delusions. The program targets apathy and anhedonia as they 
can be combined into a single reduced-experience syndrome. The 
program was built with regard to the specific deficits described 
in the literature on pleasure and motivation. The program was 
developed by beta-testing on health-care professionals and was 
improved according to the results of earlier tests. A pilot study 
was conducted with participants who met the ICD-10 criteria for 
schizophrenia or schizoaffective disorders (31). Thirty-one par-
ticipants completed the program; those who dropped out did not 
differ significantly from completers. Participation in the program 
was accompanied by statistically significant reductions in the total 
scores for avolition–apathy and anhedonia–asociality on the Scale 
for the Assessment of Negative Symptoms, with moderate effect 
sizes. Furthermore, there was a statistically significant reduction 
of depression on the CDSS, with a large effect size. Emotional 
blunting and alogia remained stable during the intervention. The 
original program in French can be downloaded for free on the 
Internet. It was designed to be easy to use and applicable in group 
sessions so as to meet the needs of community care psychiatry.
Potential shortcomings and Limitations
Positive emotions program for schizophrenia was designed using 
a recovery-oriented approach rather than a deficit-centered 
approach. The deficits of pleasure, and above all of motivation, 
may be related to factors that were not selected as targets in the 
program. This could be mainly because the authors were looking 
for a rapid, targeted intervention on the diminished experience 
syndrome. For example, apathy is associated with poor perfor-
mance on executive tests (64–66). CR has been shown to improve 
executive functioning, but although CR yields lasting effects on 
global cognition and functioning, its influence on symptom 
effects is small and disappears over time (67). However, a recent 
study indicated that anticipation abnormalities are associated 
rather to negative beliefs about potentially rewarding social situ-
ations than neurocognitive deficits (68). Motivation may also be 
affected by medication; for example, the D2 antagonistic effect of 
antipsychotic agents reduces anticipation of a monetary reward 
(69). PEPS does not include medication in its intervention.
The use of health-care professionals in the beta tests for 
developing the program may be questionable since they were 
not representative groups of people with schizophrenia. The high 
female-to-male ratio of the beta test samples did not fit with the 
high male-to-female ratio of patients with enduring schizophrenia 
(70). However, these professionals were easy to reach out to, famil-
iar with the problems surrounding schizophrenia, and able to give 
knowledgeable feedback on PEPS exercises. However, this famili-
arity with schizophrenia may also be a bias against innovation. The 
developers were well aware of these risks. The main reasons for 
the beta tests were to quickly evaluate the intervention’s feasibility, 
its impact on the self-reporting scales selected, and the program’s 
safety before the clinical phase in the development of PEPS.
Future directions
The findings presented here indicate that PEPS is indeed a feasible 
intervention, and it was associated with an apparently specific 
reduction of anhedonia and apathy. However, these findings are 
limited by the absence of a control group and the fact that the 
rater was not blind to the treatment objectives. A randomized 
controlled study with blind raters is needed to assess more cor-
rectly the efficacy of PEPS.
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